Interactive Brokers Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Interactive Brokers Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.58B | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $2.37B | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $1.93B | Feb 28, 2020 |
| FY2017 | Mar 31, 2017 | $409.00M | May 9, 2017 |
| FY2018 | Dec 31, 2016 | $1.48B | Feb 28, 2019 |
| FY2017 | Mar 31, 2016 | $507.00M | May 9, 2017 |
| FY2017 | Dec 31, 2015 | $1.26B | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $1.12B | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $1.13B | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $1.19B | Mar 2, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.44B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.98B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.56B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.51B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.57B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.29B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $847.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $925.00M | Mar 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $44.53M | Mar 2, 2015 |
| FY2014 | Dec 31, 2013 | $37.00M | Mar 2, 2015 |
| FY2014 | Dec 31, 2012 | $41.78M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $61.86M | Mar 3, 2014 |
| FY2012 | Dec 31, 2010 | ($9.55M) | Mar 8, 2013 |
| FY2011 | Dec 31, 2009 | $35.79M | Aug 31, 2012 |
| FY2010 | Dec 31, 2008 | $93.05M | Feb 28, 2011 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $314.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $211.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $165.00M | Feb 27, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.81B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.72B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $4.54B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $3.97B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $5.90B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $8.07B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.67B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.36B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.07B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $635.00M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $203.24B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $150.14B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $128.25B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $115.14B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $109.11B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $95.68B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $71.68B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $60.55B | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $61.16B | Feb 28, 2020 |
| FY2017 | Mar 31, 2017 | $56.26B | May 9, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.77B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $133.55B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $114.18B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $103.53B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $98.89B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $86.68B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $63.74B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $53.39B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $54.73B | Feb 28, 2019 |
| FY2017 | Mar 31, 2017 | $50.25B | May 9, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.36B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.28B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.58B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.85B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.40B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.95B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.45B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.28B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.09B | Feb 28, 2019 |
| FY2017 | Mar 31, 2017 | $997.00M | May 9, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.37B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.52B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.85B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.29B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $953.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $683.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $520.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $390.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $251.00M | Feb 28, 2019 |
| FY2017 | Mar 31, 2017 | $220.00M | May 9, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.96B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.63B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.75B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $3.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.40B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $4.29B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.88B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.60B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.73B | Feb 28, 2020 |
| FY2017 | Mar 31, 2017 | $1.66B | May 9, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 28, 2020 |
| FY2017 | Mar 31, 2017 | 0 | May 9, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 28, 2020 |
| FY2017 | Mar 31, 2017 | 0 | May 9, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | 63.99M | Feb 29, 2016 |
| FY2014 | Dec 31, 2014 | 58.47M | Mar 2, 2015 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $92.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $42.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $40.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $38.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $32.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $31.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $29.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $28.00M | Feb 28, 2020 |